Advanced search
Publication Cover
Journal of Drug Targeting Volume 9, 2001 - Issue 3
Submit an article Journal homepage
171
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Affinity for the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier May Explain the Lack of CNS Side-Effects of Modern Antihistamines

M. Chishty Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, London SE1 1UL, UKCorrespondence[email protected]
,
A. Reichel Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, London SE1 1UL, UK; Drug Discovery Support, Schering AG, Berlin, Germany
,
J. Siva Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, London SE1 1UL, UK
,
N. J. Abbott Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, London SE1 1UL, UK
&
D. J. Begley Blood-Brain Barrier Research Group, Centre for Neuroscience Research, GKT School of Biomedical Sciences, King's College London, London SE1 1UL, UK
Pages 223-228 | Received 08 Aug 2000, Accepted 23 Jan 2001, Published online: 08 Apr 2010

References

  • Begley D. J., Lechardeur D., Chen Z. D., Rollinson C., Bardoul M., Roux F., Scherman D., Abbott N. J. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J. Neurochem 1996; 67: 988–995
  • Emanuel M. B. Histamine and the antiallergic antihistamines: A history of their discoveries. Clin. Exp. Allergy 1999; 29: 1–11, (Suppl.)
  • Bradbury M. W. The blood-brain barrier. Exp. Physiol 1993; 78: 453–72
  • Eytan G. D., Kuchel P. W. Mechanism of action of P-glycoprotein in relation to passive membrane permeation. Int. Rev. Cytol 1999; 190: 175–250
  • Hait W. N., Gesmonde J. F., Murren J. R., Yang J. M., Chen H. X., Reiss M. Terfenadine (Seldane®): a new drug for restoring sensitivity to multidrug resistant cancer cells. Biochem. Pharmacol 1993; 45: 401–406
  • Karlstedt K., Sallmen T., Erikson K. S., Litunen M., Couraud P. O., Joo F., Panula P. Lack of histamine synthesis and down-regulation of H1 and H2 receptor mRNA levels by dexamethasone in cerebral endothelial cells. J. Cereb. Blood Flow Metab 1999; 19: 321–330
  • Nicholson A. N., Pascoe P. A., Turner C., Ganellin C. R., Greengrass P. M., Casy A. F., Mercer A. D. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br. J. Pharmacol 1991; 104: 270–276
  • Raeissi S. D., Hidalgo I. J., Segura-Aguilar J., Artusson P. Interplay between CYP3A4-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharm. Res 1999; 16: 625–632
  • Regina A., Romero I. A., Greenwood J., Adamson P., Bourre J. M., Couraud P. O., Roux F. Dexamethasone regulation of P-glycoprotein activity in immortalised rat brain endothelial cell line, GPNT. J. Neurochem 1999; 73: 1954–1963
  • Reichel A., Reeve-Chen Z. D., Begley D. J., Abbott N. J. A method to assess functional activity of P-glycoprotein in vitro based on the energy requirements of the transporter. Biology and Physiology of the Blood-Brain Barrier: Transport, Cellular Interactions and Brain Pathologies, P. O. Couraud, D. Scherman. Plenum Press, New York 1996; 183–187
  • Reichel A., Siva J., Begley D. J., Abbott N. J. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the absence of central side-effects of terfenadine. J. Physiol 1998; 515P: 4
  • Schinkel A. H. P-glycoprotein: A gatekeeper in the blood-brain barrier. Adv. Drug Del. Rev 1999; 36: 179–194
  • Schinkel A. H., Smit J. J.M., van Tellingen O., Beijnen J. H., Wagenaar E., van Deemter L., Mol C. A. A. M., van der Valk M. A., Robanus-Maandag E. C., te Riele H. P.J., Berns A. J.M., Borst P. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502
  • Schinkel A. H., Wagenaar E., Mol C. A. A. M., van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest 1996; 97: 2517–2524
  • Simons E. F.R. H1-Receptor antagonists: Comparative tolerability and safety. Drug Safety 1994; 10: 350–380
  • Taglialatela M., Timmerman H., Annunziato L. Cardio-toxic effects of first-generation antihistamines. Trends Pharmacol. Sci 2000; 21: 52–56
  • ter Laak A. M., Donné-Op den Kelder G. M., Bast A., Timmerman H. Is there a difference in the affinity of histamine H1-receptor antagonists for CNS and peripheral receptors?. Eur. J. Pharm. Sci 1993; 232: 199–205
  • ter Laak A. M., Tsai R. S., Donné-Op den Kelder G. M., Carrupt P. A., Testa B., Timmerman H. Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects. Eur. J. Pharm. Sci 1994; 2: 373–384
  • ter Laak A. M., Bijloo G. J., Fischer M. J.E., Donné-Op den Kelder G. M., Wilting J., Timmerman H. Serum protein binding of histamine H1-antagonists: A comparative study on the serum protein binding of a sedating (3H-mepyramine) and a non-sedating H1-antagonist (3H-loratadine). Eur. J. Pharm. Sci 1996; 4: 307–319
  • Timmerman H. Why are non-sedating antihistamines non-sedating?. Clin. Exp. Allergy 1999; 29: 13–18, (Suppl.)
  • Yamazaki M., Terasaki T., Yoshioka K., Nagata O., Kato H., Ito Y., Tsuji A. Carrier mediated transport of H1antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs. Pharm. Res 1994; 11: 1516–1518

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.